References
- Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364–388. doi:10.1016/j.survophthal.2005.04.003.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057.
- Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332–336. doi:10.1136/bjo.80.4.332.
- Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA- B27 uveitis. Am J Ophthalmol. 1996;121:47–56. doi:10.1016/s0002-9394(14)70533-1.
- Foxman EF, Zhang M, Hurst SD, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol. 2002;168:2483–2492. doi:10.4049/jimmunol.168.5.2483.
- Caspi Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res. 2011;31:733–744. doi:10.1089/jir.2011.0042.
- Ooi KG, Galatowicz G, Calder VL, Lightman SL. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res. 2006;4:294–309.
- Weinstein JE, Pepple KL. Cytokines in uveitis. Curr Opin Ophthalmol. 2018;29:267–274. doi:10.1097/ICU.0000000000000466.
- Carreno E, Portero A, Herreras JM, et al. Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmol. 2017;95:405–414. doi:10.1111/aos.13292.
- Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiology of uveitis in Switzerland. Ocul Immunol Inflamm. 1994;2:169–176. doi:10.3109/09273949409057073.
- Chung YM, Liao HT, Lin KC, et al. Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84–90. doi:10.1080/03009740802385423.
- Yu S, Mao C, Yu J, Qi X, Wang J, Lu H. A study of the key genes and inflammatory signaling pathways involved in HLA-B27-associated acute anterior uveitis families. Int J Mol Med. 2018;42:259–269. doi:10.3892/ijmm.2018.3596.
- Yoshimura T, Sonoda KH, Ohguro N, et al. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford). 2009;48:347–354. doi:10.1093/rheumatology/ken489.
- Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & amp; ear experience and review of previous studies. Ocul Immunol Inflamm. 2004;12:193–201. doi:10.1080/092739490500282.
- Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, et al. The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. Invest Ophthalmol Vis Sci. 2016;57:4606–4613. doi:10.1167/iovs.16-19758.
- Yao X, Huang J, Zhong H, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141:125–139. doi:10.1016/j.pharmthera.2013.09.004.
- O’Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally-occurring CD4+ Tregs: limiting collateral damage. J Clin Invest. 2004;114:1372–1378. doi:10.1172/JCI23215.
- Valentincic NV, de Groot-mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A. Intraocular and serum cytokine profiles in patients with intermediate Uveitis. Mol Vis. 2011;17:2003–2010.
- Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006;47:1557–1561. doi:10.1167/iovs.05-0836.
- Abd Elazeem Mervat I, Mohammed Rabab A, Abdallah Nilly H. Correlation of serum interleukin-10 level with disease activity and severity in systemic lupus erythematosus. Egypt Rheumatol Rehabil. 2018;45:25–33.
- Gratacos J, Collado A, Filella X, et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 1994;33:927–931. doi:10.1093/rheumatology/33.10.927.